Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07113288 · ClinicalTrials.gov registry record
Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study
A clinical trial of Obstructive Sleep Apnea (OSA), sponsored by Inspire Medical Systems.
- Recruiting
- Registry status
- 70
- Enrollment target
- 5
- Study locations
NCT07113288: Recruiting study of Obstructive Sleep Apnea (OSA), sponsored by Inspire Medical Systems.
NCT07113288 is a study of Obstructive Sleep Apnea (OSA) that is actively recruiting participants, run by Inspire Medical Systems. The registered enrollment target is 70 participants, below the 586-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (88% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07113288, a study of Obstructive Sleep Apnea (OSA), is actively recruiting participants, sponsored by Inspire Medical Systems.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this observational clinical study is to provide evaluation of long-term safety and effectiveness in a newly expanded patient population including patients with a higher AHI and a higher BMI.
Primary Outcome
Procedure-related Adverse Events; Device-related Adverse Events
Conditions Studied
Interventions
- DEVICE Inspire® UAS System
Study Locations (5)
Colorado
- Colorado ENT & Allergy - Colorado Springs
Florida
- Florida Sleep Specialists - Bradenton
Illinois
- Rush University Medical Center - Chicago
Kansas
- University of Kansas Medical Center - Kansas City
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-07-31 |
| Est. Completion | 2032-01-01 |
What NCT07113288 shows while recruiting
NCT07113288 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 586-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Obstructive Sleep Apnea (OSA) appearing as the primary indexed condition, and to 1 intervention - of which Inspire® UAS System is the first listed.
NCT07113288 lists 5 locations in 5 states (Colorado, Florida, Illinois).
Frequently Asked Questions
What is clinical trial NCT07113288 about?
NCT07113288 is a clinical study titled "Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study". The purpose of this observational clinical study is to provide evaluation of long-term safety and effectiveness in a newly expanded patient population including patients with a higher AHI and a higher BMI.
What is the current status of trial NCT07113288?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2025-07-31. Estimated completion is 2032-01-01.
What conditions does trial NCT07113288 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea (OSA).
What interventions are being tested in trial NCT07113288?
The interventions under investigation include: Inspire® UAS System (DEVICE).
Who is sponsoring clinical trial NCT07113288?
This trial is sponsored by Inspire Medical Systems, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07113288 being conducted?
This trial has 5 study locations across Colorado, Florida, Illinois, Kansas, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea (OSA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07113288's enrollment target sits among peer trials
70 4th of 12 higher than 9 of 12 other Obstructive Sleep Apnea (OSA) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea (OSA) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Circuit Rebreathing During CPAP Therapy
RECRUITING · NA
-
IOA Preventing Occlusal Changes With MAD Use
RECRUITING · NA
-
Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System
RECRUITING · NA
-
Diagnosing Obstructive Sleep Apnea Using Electromyography of the Muscles of the Mouth
RECRUITING
-
Low-Tech Treatments for Obstructive Sleep Apnea
RECRUITING · Phase 1
-
The Impact of Technology in Obstructive Sleep Apnea Myofunctional Therapy
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI